1. Natal C, Fernandez-Somoano A, Torá-Rocamora I, Vidal C, Castells X, Tardón A; Benign Lesion Study Group; Benign Lesion Study Group. Dissemination of health technologies: Trends in the use of diagnostic test in breast cancer screening. J Healthc Qual Res. 2019;34:177-184. doi: 10.1016/j.jhqr.2019.02.007. PMID: 31713528.

2. Ibáñez-Sanz G, Garcia M, Milà N, Hubbard RA, Vidal C, Binefa G, Benito L, Moreno V; Adverse Effects on Colorectal Cancer Screening in Catalonia (EACC) Study Working Group. False-Positive Results in a Population-Based Colorectal Screening Program: Cumulative Risk from 2000 to 2017 with Biennial Screening. Cancer Epidemiol Biomarkers Prev. 2019;28:1909-1916. doi: 10.1158/1055-9965.EPI-18-1368. PMID: 31488415.

3. Toribio MJ, Lope V, Castelló A, Salas D, Vidal C, Ascunce N, Santamariña C, Moreo P, Pedraz-Pingarrón C, Sánchez-Contador C, Aragonés N, Pérez-Gómez B, Pollán M. Prevalence of healthy lifestyles against cancer in Spanish women. Sci Rep. 2019;9:10638. doi: 10.1038/s41598-019-47180-x. PMID: 31337864.

4. Travier N, Vidal C, Garcia M, Benito L, Medina P, Moreno V. Communication Channels Used by Women to Contact a Population-Based Breast Cancer Screening Program in Catalonia, Spain. J Med Syst. 2019;43:244. doi: 10.1007/s10916-019-1382-6. PMID: 31236712.

5. Román M, Sala M, Baré M, Posso M, Vidal C, Louro J, Sánchez M, Peñalva L, Castells X; BELE study group. Changes in mammographic density over time and the risk of breast cancer: An observational cohort study. Breast. 2019;46:108-115. doi: 10.1016/j.breast.2019.04.007. PMID: 31132476.

6. Pérez-Lacasta MJ, Martínez-Alonso M, Garcia M, Sala M, Perestelo-Pérez L, Vidal C, Codern-Bové N, Feijoo-Cid M, Toledo-Chávarri A, Cardona À, Pons A, Carles-Lavila M, Rue M; with the InforMa Group. Effect of information about the benefits and harms of mammography on women’s decision making: The InforMa randomised controlled trial. PLoS One. 2019;14:e0214057. doi: 10.1371/journal.pone.0214057. PMID: 30913217.

7. Benito L, Travier N, Binefa G, Vidal C, Espinosa J, Milà N, Garcia M. Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program. Cancer Prev Res (Phila). 2019;12:327-334. doi: 10.1158/1940-6207.CAPR-18-0091. PMID: 30890542.

8. Buckland G, Travier N, Arribas L, Del Barco S, Pernas S, Zamora E, Bellet M, Cirauqui B, Margelí M, Muñoz M, Tusquets I, Arcusa A, Javierre C, Moreno F, Valverde Y, Jansen E, Chajès V, Castro C, Agudo A. Changes in dietary intake, plasma carotenoids and erythrocyte membrane fatty acids in breast cancer survivors after a lifestyle intervention: results from a single-arm trial. J Hum Nutr Diet. 2019;32:468-479. doi: 10.1111/jhn.12621. PMID: 30663156.

9. Posso M, Louro J, Sánchez M, Román M, Vidal C, Sala M, Baré M, Castells X; BELE study group. Mammographic breast density: How it affects performance indicators in screening programmes? Eur J Radiol. 2019;110:81-87. doi: 10.1016/j.ejrad.2018.11.012. PMID: 30599878.

10. Stoffel S, Benito L, Milà N, Travier N, Binefa G, Vidal C, Espinosa J, Moreno V, Garcia M. Testing behavioral interventions to optimize participation in a population-based colorectal cancer screening program in Catalonia, Spain. Prev Med. 2019;119:58-62. doi: 10.1016/j.ypmed.2018.12.013. PMID: 30594532.